EVs containing ACE2 were then shown to prevent infection caused by SARS-CoV-2 Spike protein, and thus blocking one of the initial infection steps through this interaction could be a viable therapeutic strategy against coronavirus [119]. This evidence concerns the gene ACE2 and infection.